Similarly, among the 113 genes, there were nine genes in common with the genes that encode the 40 CRC drug targets (ABCC1, DPYD, EGFR, FCGR2A, FCGR3A, TOP1, TYMS, VEGFA and VEGFB). This evidence concerns the gene TOP1 and colorectal carcinoma.